Barclays Scale Up UK Academic Programme Director
Andrew is the Managing Director of The Applied Knowledge Network, a marketing and strategy consultancy that also develops physical and digital products.
Andrew has a long history of identifying, developing and managing innovation within corporate environments and notably created and implemented a comprehensive and international innovation management system while working for Reuters, the European media group. His career at Reuters culminated in a role as CEO of an Asian-based Internet trading corporate spin-out in Singapore, which he took through initial VC funding and on to a trade sale.
Andrew is an accomplished author of five books on subjects that include “inventuring”, strategy, innovation and metrics, which demonstrate his extensive experience in the areas of business startup and growth and in the specialist areas of marketing, innovation management and corporate venturing.
With a personal corporate history that includes journalism, software development, venture investment, marketing and strategic sales. Andrew draws on a wealth of experience in all aspects of business management gained through working internationally, predominantly in the US and UK.
Andrew received both a bachelors in engineering and an MBA in international business from the University of London and is a Fellow of Cambridge Marketing Colleges. His specialties include strategy development, communication and implementation, innovation management and strategic marketing.
Colin is a management accountant who spent 10 years in the financial services industry, working for a mutual building society before spending the last 9 years in the software industry at Redgate Software Ltd as their CFO.
Across both roles he’s scaled & skilled up the finance teams, led on finance strategy and worked with the senior and executive management teams to deliver company strategy.
Most recently at Redgate, Colin’s work has involved international expansion, corporate structure changes, software acquisitions alongside managing the many legal, financial and compliance challenges faced through periods of sustained growth.
Jo is a coach, mentor and facilitator working with individuals and teams to enhance personal performance and creativity, leading to increased productivity in all areas of business, and wellbeing in life.
Jo has over 10 years’ experience as a senior marketeer in blue chip companies, working for M&S, Asda and Scottish & Newcastle Breweries. She successfully project-managed the launch of the George Davis clothing range into Asda Stores in the 1990s.
Jo founded and successfully ran a personalised printing business for 15 years, supplying name labels to customers of Tesco, Great Little Trading Company and Mothercare as well as direct to the public. Her specialties are marketing, business development, creative leadership, women in business, performance optimisation and problem solving.
Chris has significant experience in pharma, biotech and healthcare, and is an internationally recognised company director with a sustained record of achievement in global pharmaceuticals, healthcare technology and management consultancy. He was UK Sales and Marketing Director at AstraZeneca before joining Dendrite as Global Vice President, where his focus was on optimising commercialisation.
Since 2002, he has provided commercialisation and management consultancy to global pharma as Marketing Partner (and currently Company Director) at Oxford PharmaGenesis, an internationally renowned HealthScience communication consultancy which was recognised by the Queen’s Award for Enterprise in 2015. His expertise includes global launch excellence and strategic brand planning for more than 15 brands across a wide range of therapy areas, driving commercial excellence and new selling models, and providing management coaching on a one-to-one basis exclusively with CEOs and board directors.
Chris has practical hands-on experience in growing and shaping businesses of all sizes and at all stages – new or early ventures, SMEs or top 10 pharma – and supporting them in realising commercial opportunities and developing business models for scaleable growth to achieve maximum commercial success and shareholder value.
Chris has experience in Europe, US, APAC and LATAM and is particularly interested in personalised medicine, genomics and wearables, encompassing access to doctors, access to medicines and advances in early diagnosis. His specialty is coaching in pharma, biotech, healthcare, wearables and healthcare technology.
Anne Marieke Ezendam
Anne Marieke has been an all-round investor in the healthcare space for over 20 years. She is known for advising startup life sciences companies in the pre-IPO stage, but has also been sought out by the C-suite of large multinationals, which has resulted in a strong network in the industry. She has excelled in developing financial workshops to create a thorough understanding of business models across all industries for graduate students and mature analysts across the firms she has worked for within the asset management industry. Going forward she wants to help companies to develop their business model to optimise what is achievable with their three main assets: technology, human capital and cash. She is a strong believer of the ESG rationale to build a more sustainable business in the long run.
Her career in the City started as a proprietary trader at Gulf International Bank working across the bond and equity desks. She joined Threadneedle in 2002, to become global head of healthcare within a year. At Threadneedle, she managed the healthcare fund, which was best performer after five years on Morningstar and the Amex innovation fund which outperformed >5 per cent year. She moved to Credit Suisse to manage a wider range of healthcare funds, which was cut short when Credit Suisse sold the asset management arm after the financial crisis. After a short period working for a boutique sell-side firm she joined ING (now NN) asset management as the sole healthcare analyst, only to join Amundi in London two years later where she ended up running $2bn in equity as deputy global fund manager towards the end of 2018. Anne Marieke joined a life sciences communication firm in 2018 to increase her knowledge of how to position a company in the media to optimise the chances to raise sufficient funds and attract key hires.
Version 1 (1 October 2019)